- Home
- MRNA vs IBKR Comparison
MRNA vs IBKR Comparison
Compare MRNA & IBKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- IBKR
- Stock Information
- Founded
- MRNA 2010
- IBKR 1977
- Country
- MRNA United States
- IBKR United States
- Employees
- MRNA N/A
- IBKR N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- IBKR Investment Bankers/Brokers/Service
- Sector
- MRNA Health Care
- IBKR Finance
- Exchange
- MRNA Nasdaq
- IBKR Nasdaq
- Market Cap
- MRNA 16.0B
- IBKR 18.9B
- IPO Year
- MRNA 2018
- IBKR 2007
- Fundamental
- Price
- MRNA $28.56
- IBKR $166.17
- Analyst Decision
- MRNA Hold
- IBKR Strong Buy
- Analyst Count
- MRNA 20
- IBKR 8
- Target Price
- MRNA $54.82
- IBKR $204.13
- AVG Volume (30 Days)
- MRNA 9.3M
- IBKR 2.6M
- Earning Date
- MRNA 05-01-2025
- IBKR 04-15-2025
- Dividend Yield
- MRNA N/A
- IBKR 0.61%
- EPS Growth
- MRNA N/A
- IBKR 22.22
- EPS
- MRNA N/A
- IBKR 6.93
- Revenue
- MRNA $3,236,000,000.00
- IBKR $5,200,000,000.00
- Revenue This Year
- MRNA N/A
- IBKR $7.00
- Revenue Next Year
- MRNA $23.65
- IBKR $7.24
- P/E Ratio
- MRNA N/A
- IBKR $23.77
- Revenue Growth
- MRNA N/A
- IBKR 17.65
- 52 Week Low
- MRNA $29.25
- IBKR $103.69
- 52 Week High
- MRNA $170.47
- IBKR $236.53
- Technical
- Relative Strength Index (RSI)
- MRNA 34.78
- IBKR 36.34
- Support Level
- MRNA $31.52
- IBKR $170.45
- Resistance Level
- MRNA $34.87
- IBKR $183.73
- Average True Range (ATR)
- MRNA 1.74
- IBKR 6.71
- MACD
- MRNA -0.37
- IBKR 0.15
- Stochastic Oscillator
- MRNA 15.53
- IBKR 33.79
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About IBKR Interactive Brokers Group Inc.
Interactive Brokers is an online brokerage that generates trading commissions (around 31% of net revenue) from facilitating trading in a wide range of products, including equity, options, futures, foreign exchange, bonds, mutual funds, and ETFs. Interactive Brokers also generates net interest income (about 64% of net revenue) from idle client cash and earns fees (about 6% of net revenue) from ancillary services. Principal trading and other miscellaneous activities are small (about 5% of net revenue). The firm derives about 70% of its net revenue from the U.S. and 30% from international markets.